↓ Skip to main content

Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway

Overview of attention for article published in BMC Cancer, February 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway
Published in
BMC Cancer, February 2014
DOI 10.1186/1471-2407-14-96
Pubmed ID
Authors

Ting Li, Qunling Zhang, Jian Zhang, Gong Yang, Zhimin Shao, Jianmin Luo, Minhao Fan, Chen Ni, Zhenhua Wu, Xichun Hu

Abstract

There are a lot of unmet needs in patients with triple-negative breast cancer (TNBC). Fenofibrate, a peroxisome proliferator-activated receptor alpha (PPAR-α) agonist, has been used for decades to treat hypertriglyceridaemia and mixed dyslipidaemia. Recent studies show that it might have anti-tumor effects, however, the mechanism remains unclear. Here, we assessed the ability of fenofibrate to induce apoptosis of TNBC in vitro and in vivo and explored involved mechanisms.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 55 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 23%
Student > Ph. D. Student 11 20%
Student > Doctoral Student 4 7%
Professor 4 7%
Student > Postgraduate 4 7%
Other 11 20%
Unknown 9 16%
Readers by discipline Count As %
Medicine and Dentistry 11 20%
Biochemistry, Genetics and Molecular Biology 9 16%
Agricultural and Biological Sciences 9 16%
Pharmacology, Toxicology and Pharmaceutical Science 6 11%
Nursing and Health Professions 4 7%
Other 9 16%
Unknown 8 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 February 2014.
All research outputs
#11,875,691
of 21,363,193 outputs
Outputs from BMC Cancer
#2,421
of 7,684 outputs
Outputs of similar age
#90,857
of 202,301 outputs
Outputs of similar age from BMC Cancer
#1
of 1 outputs
Altmetric has tracked 21,363,193 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,684 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 202,301 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them